Records Retained. Throughout the term of this Agreement and for 5 years thereafter, Adaptimmune, at its expense, shall keep and maintain and shall cause each Sublicensee to keep and maintain complete and accurate records of all sales, leases, and other dispositions of Licensed Products during the term of this Agreement and all other records related to this Agreement.
Appears in 3 contracts
Sources: Research Collaboration and License Agreement (Adaptimmune Therapeutics PLC), Research Collaboration and License Agreement (Adaptimmune Therapeutics PLC), Hla/Aav Sublicence (Adaptimmune Therapeutics PLC)